Globeflex Capital »

Theravance Biopharma shares owned by Globeflex Capital

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $171k 11k 16.23

More positions owned by Globeflex Capital

Intercorp Financial Services (IFS)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Blue Bird Corp (BLBD)
Exelixis (EXEL)
Catalyst Pharmaceutical Partners (CPRX)
Cirrus Logic (CRUS)
Ypf Sa (YPF)
Allegheny Technologies Incorporated (ATI)
Copa Holdings Sa-class A (CPA)
EnerSys (ENS)
Marex Group (MRX)
Credicorp (BAP)
ESCO Technologies (ESE)
MKS Instruments (MKSI)
Costamare (CMRE)

View all positions for Globeflex Capital

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Vanguard Capital Management
Acadian Asset Management
Two Sigma Investments
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
UBS Group

View all funds holding Theravance Biopharma